Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Income from Non-Controlling Interests (2016 - 2022)

Aethlon Medical filings provide 10 years of Income from Non-Controlling Interests readings, the most recent being -$413.0 for Q2 2022.

  • On a quarterly basis, Income from Non-Controlling Interests rose 63.61% to -$413.0 in Q2 2022 year-over-year; TTM through Mar 2023 was -$413.0, a 91.39% increase, with the full-year FY2022 number at -$4794.0, changed 0.08% from a year prior.
  • Income from Non-Controlling Interests hit -$413.0 in Q2 2022 for Aethlon Medical, up from -$620.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$413.0 in Q2 2022 to a low of -$8715.0 in Q3 2018.
  • Median Income from Non-Controlling Interests over the past 5 years was -$1543.5 (2019), compared with a mean of -$2676.7.
  • Biggest five-year swings in Income from Non-Controlling Interests: crashed 86.58% in 2018 and later soared 86.01% in 2019.
  • Aethlon Medical's Income from Non-Controlling Interests stood at -$5940.0 in 2018, then surged by 77.14% to -$1358.0 in 2019, then dropped by 10.31% to -$1498.0 in 2020, then plummeted by 47.8% to -$2214.0 in 2021, then soared by 81.35% to -$413.0 in 2022.
  • The last three reported values for Income from Non-Controlling Interests were -$413.0 (Q2 2022), -$620.0 (Q1 2022), and -$2214.0 (Q4 2021) per Business Quant data.